Medtronic (NYSE:MDT) said today that the FDA approved its Resolute Onyx drug-eluting stent.
The Fridley, Minn.-based company touted its device as the 1st stent formed by a sinusoidal wave of cobalt alloy wire. The company incorporated a radiopaque inner core within the wire to boost visibility, according to Medtronic. The stent also features thin struts and a polymer blend that minimizes inflammation and risk of stent thrombosis.
Get the full story at our sister site, Drug Delivery Business News.
